How research peptides sit inside the Australian regulatory framework — what the Poisons Standard is, what Research Use Only actually means, and how to check a specific compound's status yourself rather than taking a supplier's word for it.
This page is general information, not legal advice. It describes how the framework works so you can look things up yourself. It does not tell you the status of any particular compound, because scheduling changes and because your obligations depend on your jurisdiction and what you intend to do. Confirm your own position against current TGA guidance and your state or territory health authority.
Three layers apply, and people frequently conflate them.
The TGA itself makes the last point explicitly: for definitions specific to your jurisdiction, you need to check with the relevant state or territory authority.
The Poisons Standard — formally the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) — classifies medicines and poisons into Schedules according to the degree of risk and the level of control considered appropriate over their availability to the public.
Schedules 2, 3, 4 and 8 cover medicinal substances intended for human therapeutic use, with increasingly restrictive controls in that order. The two that come up most often in peptide discussions:
Part 5 of the Standard contains appendices setting out additional restrictions and exemptions that apply to some substances under particular conditions. If you are checking a compound's status, the appendices matter as much as the schedule entry.
Research Use Only (RUO) describes what a material is supplied as: a laboratory reference material, not a therapeutic good. RUO material carries no therapeutic claims, is not represented as suitable for human or veterinary use, is not registered on the ARTG, and has not been assessed by the TGA for safety, quality or efficacy for any therapeutic purpose.
What RUO is not: it is not a loophole, an exemption, or a workaround. Supplying a material as RUO does not change what the substance is, and it does not remove a substance from the Poisons Standard. A compound that is scheduled remains scheduled regardless of how it is labelled. The RUO designation describes the terms of supply; it does not confer permission to use the material in a person.
Where suppliers get into difficulty is the gap between the two: labelling a product RUO while marketing it with dosing guidance, before-and-after imagery, or health benefit claims. The label and the marketing have to tell the same story.
Australia restricts advertising therapeutic goods to the public, and the restrictions are tighter for prescription-only substances. The TGA publishes a decision tree specifically for working out whether a given good may be advertised to the public, with a dedicated branch for Schedule 4 and Schedule 8 substances.
For a supplier of research materials, the practical consequence is straightforward: we describe what a compound is and what the published literature has studied, in third person and with attribution. We do not publish dosing protocols, administration routes, cycle guidance, or any claim that a compound treats, prevents or improves a condition. Our reconstitution calculator does concentration arithmetic — millilitres, milligrams, IU on a syringe barrel — and deliberately stops there.
If a supplier is willing to tell you how much to inject, that tells you something about how carefully they are treating the rest of their obligations, including the ones that affect what is actually in the vial.
This is the part worth learning, because it is the only answer that stays correct as the Standard changes.
If you are working in an institution, your research governance office will generally have a standing process for this — it is usually faster than doing it yourself, and it produces a record.
Two obligations sit with the buyer, and neither transfers to a supplier.
What a supplier can be held to is the quality of what arrives: whether the vial contains what the label says, at the purity stated, with documentation you can check independently. That is the part we publish — every certificate we hold, with batch numbers and test dates, is on the CoA library, and we name the laboratory rather than saying "an accredited third party". Our sourcing and quality-control process is documented on the about page.
The question is too broad to have one answer. "Peptides" covers hundreds of distinct molecules with different regulatory status. Some are scheduled substances requiring a prescription; some are not scheduled at all; some are registered medicines; some have never been assessed. The status also depends on what you intend to do with the material. The useful version of the question is always about a specific compound, a specific jurisdiction and a specific purpose.
No. The RUO designation describes the basis on which material is supplied — as a laboratory reference material with no therapeutic claims. It does not alter the substance's status under the Poisons Standard, and it does not authorise human use.
Not by itself. It has legal effect through state and territory legislation, which each jurisdiction adopts and may vary. Your obligations come from your state or territory's drugs-and-poisons law.
Yes, and it does. The TGA runs a public scheduling process with interim and final decisions, and the consolidated Standard is reissued periodically. A status you confirmed a year ago may no longer hold, which is why it is worth checking the current Standard rather than relying on a secondary source — including this page.
Because publishing dosing or administration guidance for these substances to the public is precisely what Australian advertising restrictions prohibit, and because we supply laboratory reference materials rather than therapeutic goods. The calculator handles concentration arithmetic and stops at that boundary deliberately.
No. They are laboratory reference materials, not therapeutic goods. They are not on the ARTG, have not been assessed by the TGA for safety, quality or efficacy, and are not for human or veterinary use or consumption.
Go to these rather than to any vendor summary, including this one: